Impact of Fc receptors and host characteristics on myeloid phagocytic response to rituximab-treated 3D-cultured B-cell lymphoma [0.03%]
Fc受体和宿主特性对利妥昔单抗治疗的三维培养B细胞淋巴瘤的髓系吞噬反应的影响
Sandra Kleinau
Sandra Kleinau
Antibody-based immunotherapy is successful in treating cancer, but its effectiveness varies among patients. Therefore, understanding myeloid phagocytic responses to therapeutic antibodies is critical. Immunoglobulin Fc receptors and host ch...
Human infection challenge in the pandemic era and beyond, HIC-Vac annual meeting report, 2022 [0.03%]
大流行时代的人感染攻击性试验国际研讨会（HIC-VAC年度会议报告）2022年版
Megan V C Barnes,Anika Mandla,Emma Smith et al.
Megan V C Barnes et al.
HIC-Vac is an international network of researchers dedicated to developing human infection challenge studies to accelerate vaccine development against pathogens of high global impact. The HIC-Vac Annual Meeting (3rd and 4th November 2022) b...
Ester Gea-Mallorquí,Sarah Rowland-Jones
Ester Gea-Mallorquí
Lentivectors (LVs) induce sustained transgene expression and are attractive vaccine platforms for complex immune scenarios like cancer and persistent infections. This review summarises the literature on lentivectors with potential uses for ...
Efficacy of PD-1 checkpoint inhibitor therapy in melanoma and beyond: are peripheral T cell phenotypes the key? [0.03%]
PD-1检查点抑制剂治疗黑色素瘤及其他疾病的有效性：周边T细胞表型是关键因素吗？
Katie R Flaherty,Stephanie Kucykowicz,Johannes Schroth et al.
Katie R Flaherty et al.
Immunotherapy treatment strategies have proven effective in a limited portion of patients, where identifying responders from non-responders to treatment remains a challenge. While some indications can be drawn from invasive biopsies, we nee...
Melissa M Christodoulidou,Neil A Mabbott
Melissa M Christodoulidou
The Mpox virus (MPXV) is endemic in certain countries in Central and West Africa, where several mammalian species, especially rodents, are natural reservoirs. However, the MPXV can infect nonhuman primates and cause zoonotic infections in h...
[This corrects the article DOI: 10.1093/immadv/ltac022.]. © The Author(s) 2023. Published by Oxford University Press on behalf of the British Society fo...
Published Erratum
Immunotherapy advances. 2023 Oct 12;3(1):ltad017. DOI:10.1093/immadv/ltad017 2023
Correction to: Blockade of innate inflammatory cytokines TNFα, IL-1β, or IL-6 overcomes virotherapy-induced cancer equilibrium to promote tumor regression [0.03%]
Correction to: 阻止天然炎症细胞因子 TNFα、IL-1β 或 IL-6 可克服病毒疗法引起的肿瘤平衡以促进肿瘤消退
[This corrects the article DOI: 10.1093/immadv/ltad011.]. © The Author(s) 2023. Published by Oxford University Press on behalf of the British Society fo...
Published Erratum
Immunotherapy advances. 2023 Oct 12;3(1):ltad019. DOI:10.1093/immadv/ltad019 2023
Correction to: TIM-3: a tumor-associated antigen beyond checkpoint inhibition? [0.03%]
Correction to: TIM-3：超越检查点抑制的肿瘤相关抗原？
[This corrects the article DOI: 10.1093/immadv/ltac021.]. © The Author(s) 2023. Published by Oxford University Press on behalf of the British Society fo...
Published Erratum
Immunotherapy advances. 2023 Oct 12;3(1):ltad018. DOI:10.1093/immadv/ltad018 2023
Lars Klareskog,Lars Alfredsson
Lars Klareskog
Whether a yet chronic and not curable disease like rheumatoid arthritis (RA) can be subject to prevention or whether available resources should be focused on treatment is a classical dilemma. Similar to the case in most other chronic diseas...
Walter Bodmer
Walter Bodmer
The discovery of the history of the HLA system is reviewed from the earliest attempts at cancer transfers between mice, through the discovery of the mouse H-2 system on mouse red blood cells, the discovery of HLA class II and II antigens by...